title: The patient's CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide.
authors.affiliation: Department of Oncology, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: R
authors.initials: R
authors.lastname: Crocchiolo
authors.affiliation: Department of Oncology, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Castagna
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: S
authors.initials: S
authors.lastname: Furst
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: R
authors.initials: R
authors.lastname: Devillier
authors.affiliation: Department of Oncology, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Sarina
authors.affiliation: Department of Oncology, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: S
authors.initials: S
authors.lastname: Bramanti
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: J
authors.initials: J
authors.lastname: El-Cheikh
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: A
authors.initials: A
authors.lastname: Granata
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: S
authors.initials: S
authors.lastname: Harbi
authors.affiliation: Department of Oncology, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Morabito
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Faucher
authors.affiliation: Department of Oncology, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Rimondo
authors.affiliation: Department of Oncology, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: D
authors.initials: D
authors.lastname: Girardi
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: B
authors.initials: B
authors.lastname: Mohty
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: B
authors.initials: B
authors.lastname: Calmels
authors.affiliation: Department of Oncology, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: C
authors.initials: C
authors.lastname: Carlo-Stella
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: C
authors.initials: C
authors.lastname: Chabannon
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: R
authors.initials: R
authors.lastname: Bouabdallah
authors.affiliation: Department of Oncology, Humanitas Clinical and Research Center, Rozzano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Santoro
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: N
authors.initials: N
authors.lastname: Vey
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: P J
authors.initials: PJ
authors.lastname: Weiller
authors.affiliation: Department of Hematology, Institut Paoli-Calmettes, Marseille, France.
authors.forename: D
authors.initials: D
authors.lastname: Blaise
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D015331:Cohort Studies; D003520:Cyclophosphamide / Q000627:therapeutic use; D003586:Cytomegalovirus Infections; D005260:Female; D019337:Hematologic Neoplasms / Q000150:complications / Q000401:mortality / Q000628:therapy; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects* / Q000379:methods / Q000401:mortality; D006801:Humans; D008212:Lymphocyte Depletion; D008297:Male; D008875:Middle Aged; D000075442:Transplantation, Haploidentical / Q000009:adverse effects*; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D003520:Cyclophosphamide